Results 271 to 280 of about 855,799 (394)

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

Advanced Healthcare Materials, EarlyView.
Centralizes the microbiome within 3D tumor‐microbiome model platforms, including spheroids, organoids, 3D‐bioprinted constructs, and microfluidic chips, each enabling structured host‐tumor‐microbe studies. These systems support bacterial colonization, facilitating investigation of microbial impacts on tumor growth, immunity, and therapy. The microbiome
Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky, Opal Avramoff, Anshika Katyal, Koren Salomon, Adan Miari, Dana Venkert, Tania T. Barnatan, América García Alvarado, Shahar Greenberg, Ronit Satchi‐Fainaro   +12 more
wiley   +1 more source

Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry. [PDF]

Clin Kidney J
Nguyen MD, Fekrat R, Gee C, Demirci AN, Kharabaf S, Le D, Tadros M, Nguyen VQ, Patel S, Truong T, Ahdoot R, Kurtz IB, Kerr M, Massoud A, Hanna R.   +14 more
europepmc   +1 more source

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

Nature Medicine, 2001
P. Carmeliet, L. Moons, A. Luttun, V. Vincenti, V. Compernolle, M. D. Mol, WU Yan, F. Bono, L. Devy, H. Beck, D. Scholz, T. Acker, T. Dipalma, M. Dewerchin, A. Noel, I. Stalmans, A. Barra, S. Blacher, T. VandenDriessche, A. Pontén, U. Eriksson, Karl H. Plate, J. Foidart, W. Schaper, D. Charnock-Jones, D. Hicklin, J. Herbert, D. Collen, M. Persico   +28 more
semanticscholar   +1 more source

Microphysiological Systems of Lymphatics and Immune Organs

Advanced Healthcare Materials, EarlyView.
This review surveys recent progress in engineering lymphatic microenvironments and immune organoids within microphysiological systems, emphasizing innovative strategies to recreate the biochemical and biophysical complexity of native lymphatic tissues.
Ishita Jain, Ankur Singh, Andrés J. García   +2 more
wiley   +1 more source

Immune checkpoint inhibitor resistance in non-small cell lung cancer: limits of vascular endothelial growth factor inhibition and new directions. [PDF]

J Thorac Dis
Kaneda H.
europepmc   +1 more source

The roles of vascular endothelial growth factor in bone repair and regeneration.

Bone, 2016
Kai Hu, B. Olsen
semanticscholar   +1 more source

Development of a Synthetic 3D Platform for Compartmentalized Kidney In Vitro Disease Modeling

Advanced Healthcare Materials, EarlyView.
A fully synthetic, compartmentalized 3D kidney disease model is introduced. The kidney model combines a PEG‐based hydrogel matrix with anisotropic, enzymatically degradable rod‐shaped microgels to spatially arrange a triple co‐culture of key renal epithelial, endothelial, and fibroblast cells.
Ninon Möhl, Daphne Bouwens, Johanna Abele, Aline Hans, Tanja Topic, Daniel Günther, Jitske Jansen, Rafael Kramann, Laura De Laporte   +8 more
wiley   +1 more source

"Diamonds Are Forever": Novel Vascular Endothelial Growth Factor-Nanodiamond Therapy for the Treatment of Congenital Diaphragmatic Hernia. [PDF]

Am J Respir Crit Care Med
Damianos A, Thébaud B, Kalinichenko VV.
europepmc   +1 more source

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.

Journal of Clinical Oncology, 2006
R. Motzer, M. Michaelson, B. Redman, G. Hudes, G. Wilding, R. Figlin, M. Ginsberg, Sindy T. Kim, C. Baum, S. Deprimo, Jim Z. Li, C. Bello, C. Theuer, D. George, B. Rini   +14 more
semanticscholar   +1 more source

Plasma‐Polymerized Nanoparticles Presenting Fibrillin‐1 Drive Rapid Re‐Endothelialization of Vascular Grafts

Advanced Healthcare Materials, EarlyView.
Commercial vascular grafts are made from ePTFE, a highly hydrophobic, foreign material that fails at a high rate in small‐diameter applications. Plasma polymer nanoparticles (PPN) are a versatile material functionalisation tool, used here to present fibrillin‐1 fragment PF8 on the graft surface.
Bob S. L. Lee, Yuen Ting Lam, Alex H. P. Chan, Praveesuda L. Michael, Timothy C. Mitchell, Jui Chien Hung, Miguel Santos, Khoon S. Lim, Richard P. Tan, Steven G. Wise   +9 more
wiley   +1 more source